cDNA Library Bias Reduction via TdT Tailing and Affinity Enrichment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for creating cDNA libraries from RNA samples are often biased, particularly due to partial degradation and uneven representation of RNA sequences, which complicates data analysis and transcriptional pattern assessment.

Innovation Solution

A method involving the addition of an affinity tag-labeled guanosine monophosphate (GMP) to the 5' end of RNA molecules, followed by enrichment using an affinity matrix, reverse transcription, and the use of terminal transferase (TdT) to add a tail to the 3' end of cDNAs, reducing bias and enabling more efficient second strand synthesis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If template switching method is used to add adaptor sequence at 3' end of cDNA, then cDNA library can be constructed, but significant bias is introduced favoring specific nucleotides at 5' end of mRNA

Engineering Contradiction:
ImprovecDNA library constructionVSAvoidnucleotide representation accuracy
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent introduces terminal transferase (TdT) as an intermediary enzyme that adds non-templated nucleotides (tails) to the 3' end of cDNA. This mediator approach replaces the biased template switching mechanism with a controlled enzymatic reaction that uniformly processes all cDNA molecules regardless of their 5' end nucleotide composition, thereby eliminating the bias while maintaining library construction efficiency

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the reaction parameter from template-dependent (template switching) to template-independent (TdT-mediated tailing). By altering the fundamental mechanism from sequence-specific annealing to enzymatic addition, the method achieves uniform processing of all transcripts. The TdT enzyme adds a standardized tail sequence to every cDNA molecule, ensuring equal representation of all nucleotide types at the 5' end of original mRNA

Inventive Principle:
Principle #35Parameter changes

2Productivity

If RNA samples are used that are partially degraded, then cDNA library can be made, but cDNAs are neither long nor full length leading to data analysis problems

Engineering Contradiction:
ImprovecDNA library productionVSAvoidcDNA length and completeness
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent applies preliminary enrichment of full-length RNA molecules before cDNA synthesis by using affinity tags to select intact transcripts. This preliminary action ensures that only complete, undegraded RNA molecules are converted to cDNA, guaranteeing full-length products. The enrichment step occurs before the irreversible cDNA synthesis, preventing propagation of degradation artifacts

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses affinity tags as intermediaries to separate full-length RNA from degraded fragments. The affinity tag binds specifically to intact transcripts through size-dependent or sequence-specific recognition, acting as a mediator that selectively captures desired molecules while excluding degraded ones. This intermediary selection process ensures high-quality template for subsequent cDNA synthesis

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If affinity tag-labeled GMP is added to 5' end of RNA molecules followed by affinity matrix enrichment, then targeted RNA can be enriched, but additional steps are required compared to direct methods

Engineering Contradiction:
ImproveRNA enrichment accuracyVSAvoidnumber of processing steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent performs preliminary labeling of RNA molecules with affinity tags before enrichment. This preliminary action modifies the RNA to enable subsequent affinity-based separation. The labeling step prepares the molecules in advance for high-specificity capture on the affinity matrix, ensuring that only tagged (and therefore targeted) RNAs are enriched while minimizing off-target binding

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The affinity tag serves as an intermediary that bridges the targeted RNA and the affinity matrix. The tag is a small molecular component that provides high-affinity binding to the matrix while being minimally invasive to the RNA structure. This intermediary approach allows specific enrichment of targeted RNAs from complex mixtures through a single, highly selective binding step

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces bias in cDNA library creation, allowing for more accurate and unbiased representation of RNA sequences, enhancing data analysis and transcriptional pattern identification.

Implementation Method 1

adding an affinity tag-labeled GMP to the 5' end of targeted RNA species in a sample by incubating the sample with an affinity tag-labeled GTP and a capping enzyme

Methodology Applied
Scientific EffectEnzymatic capping: Enzyme

Implementation Method 2

enriching for RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag

Methodology Applied
Scientific EffectAffinity binding: Adsorption

Implementation Method 3

adding a tail to the 3' end of the population of cDNAs using a TdT

Methodology Applied
Scientific EffectTerminal transferase activity: Enzyme

Data Source

PatentUS11225658B2Enrichment and sequencing of RNA species
Publication Date: 2022.01.18 NEW ENGLAND BIOLABS INC
  • US11225658B2 patent drawing
  • US11225658B2 patent drawing
  • US11225658B2 patent drawing

AI summary

Provided herein is a method for making an cDNA library, comprising adding an affinity tag-labeled GMP to the 5′ end of targeted RNA species in a sample by optionally decapping followed by incubating the sample with an affinity tag-labeled GTP and a capping enzyme, enriching for RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag, reverse transcribing the enriched RNA to produce a population of cDNAs, and adding a tail to the 3′ end of the population of cDNAs using a terminal transferase, to produce an cDNA library.